Kidney RSS News Feeds

Nephrology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Trappe R et al. – The immunosuppressive effect of single agent rituximab may partially compensate the negative impact of IR on the graft function. Thus, it is possible to reduce immunosuppression when using chemotherapy to treat PTLD.

Related Articles

Impact of Donor-Dependent Genetic Factors on Long-Term Renal Graft Function
Transplantation Proceedings, 11/10/09    Relevance Score: 67%

Is short term outcome of Iranian renal transplant recipients affected by mean first 6 months C2 level
Saudi Journal of Kidney Diseases and Transplantation, 11/10/09    Relevance Score: 67%

1,25-Dihydroxyvitamin D Deficiency Predicts Poorer Outcome After Renal Transplantation
Transplantation Proceedings, 10/29/09    Relevance Score: 67%

Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients
Kidney International, 10/28/09    Relevance Score: 67%

Conservative management of an extensive renal graft subcapsular hematoma arising during living donor nephrectomy. Role of Doppler sonographic posttransplant follow-up
Journal of Clinical Ultrasound, 10/26/09    Relevance Score: 67%

Today in Pharmacology/kinetics...keeping you current

Efficacy of low-dose i.v. iron therapy in haemodialysis patients
Nephrology, 12/02/09

Long-term mycophenolate mofetil treatment in pediatric renal transplant patients
Dialysis & Transplantation, 12/02/09

Nebivolol Improves Renal Function in Patients Who Underwent Angioplasty due to Renal Artery Stenosis: A Pilot Study
Nephron: Clinical Practice, 12/01/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address